Peeter Karihtala

24PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumoursTumour immunologyEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Apr 29, 2026
Insights on postneoadjuvant treatment among patients with triple-negative breast cancer and residual disease after neoadjuvant therapy: can expert consensus help to interpret the current evidence?

|Feb 19, 2026
Real-world outcome of neoadjuvant therapy with or without pembrolizumab for triple-negative breast cancer.

Meeri Maunu, Juho Lähteenmaa, Peeter Karihtala

|Oct 09, 2025
Impact of the COVID-19 pandemic on the quality of life of early breast cancer patients undergoing adjuvant chemotherapy - an observational, multicenter study.

Marie Tuomarila, Paula Poikonen-Saksela, Haridimos Kondylakis

|Jun 25, 2025
How to choose optimal adjuvant therapies for high-risk hormone receptor-positive, HER2-negative breast cancer after chemotherapy?

Peeter Karihtala

|Sep 26, 2024
Depression and Anxiety Symptoms Before and After Breast-Cancer Diagnosis Among Young Women in the Northern Finland Birth Cohort 1966.

Anniina Tastula, Arja Jukkola, Anni-Emilia Alakokkare

|Sep 25, 2024
Prevalence, prognosis, and health care resource utilization in carriers of pathogenic germline variants in BRCA1/2 with incident early-stage breast cancer: a Finnish population-based study.

Peeter Karihtala, Outi Laatikainen, Samuli Tuominen

Pageof 4

Frequent Collaborators

2 joint publications

Elina Urpilainen

2 joint publications

Anniina Jääskeläinen

2 joint publications

Arja Jukkola

2 joint publications

Johanna Mattson